| Literature DB >> 19551466 |
Wacław Kolasiewicz1, Katarzyna Kuter, Jadwiga Wardas, Krystyna Ossowska.
Abstract
The present study shows that JNJ 16259685-a selective antagonist of glutamate metabotropic receptor subtype 1 (mGluR1) injected in doses of 0.16 and 0.32 mg/kg sc strongly enhances tremor of forelimbs, head and trunk, hypolocomotion, and ataxia induced by harmaline (7.5 mg/kg ip) in rats. JNJ 16259685 inhibited locomotor and exploratory activity per se. These results may suggest an inhibitory influence of mGluR1 on the harmaline-induced motor disturbances.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19551466 DOI: 10.1007/s00702-009-0254-5
Source DB: PubMed Journal: J Neural Transm (Vienna) ISSN: 0300-9564 Impact factor: 3.575